These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 27791197)

  • 1. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
    Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
    Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.
    Singh AK; Umar S; Riegsecker S; Chourasia M; Ahmed S
    Arthritis Rheumatol; 2016 Feb; 68(2):347-58. PubMed ID: 26473505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity.
    Hu L; Xu J; Xie X; Zhou Y; Tao P; Li H; Han X; Wang C; Liu J; Xu P; Neculai D; Xia Z
    Nat Commun; 2017 Oct; 8(1):814. PubMed ID: 28993672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAF6 regulates melanoma invasion and metastasis through ubiquitination of Basigin.
    Luo Z; Zhang X; Zeng W; Su J; Yang K; Lu L; Lim CB; Tang W; Wu L; Zhao S; Jia X; Peng C; Chen X
    Oncotarget; 2016 Feb; 7(6):7179-92. PubMed ID: 26769849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.
    Lamothe B; Besse A; Campos AD; Webster WK; Wu H; Darnay BG
    J Biol Chem; 2007 Feb; 282(6):4102-12. PubMed ID: 17135271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation.
    Hinz M; Stilmann M; Arslan SÇ; Khanna KK; Dittmar G; Scheidereit C
    Mol Cell; 2010 Oct; 40(1):63-74. PubMed ID: 20932475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
    Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
    Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
    He Z; Huang C; Lin G; Ye Y
    Oncol Rep; 2016 Apr; 35(4):1933-40. PubMed ID: 26847475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
    Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
    Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6.
    Min Y; Wi SM; Kang JA; Yang T; Park CS; Park SG; Chung S; Shim JH; Chun E; Lee KY
    Cell Death Dis; 2016 Jul; 7(7):e2313. PubMed ID: 27468689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells.
    Schnetzke U; Fischer M; Kuhn AK; Spies-Weisshart B; Zirm E; Hochhaus A; Müller JP; Scholl S
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):605-15. PubMed ID: 23263202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
    Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
    Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation.
    Min Y; Kim MJ; Lee S; Chun E; Lee KY
    Autophagy; 2018; 14(8):1347-1358. PubMed ID: 29929436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.
    Ji YX; Zhang P; Zhang XJ; Zhao YC; Deng KQ; Jiang X; Wang PX; Huang Z; Li H
    Nat Commun; 2016 Jun; 7():11267. PubMed ID: 27249171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Cbl negatively regulates TRAF6-mediated NF-
    Jang HD; Hwang HZ; Kim HS; Lee SY
    Cell Mol Biol Lett; 2019; 24():29. PubMed ID: 31123462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
    Sun L; Deng L; Ea CK; Xia ZP; Chen ZJ
    Mol Cell; 2004 May; 14(3):289-301. PubMed ID: 15125833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.
    Brenke JK; Popowicz GM; Schorpp K; Rothenaigner I; Roesner M; Meininger I; Kalinski C; Ringelstetter L; R'kyek O; Jürjens G; Vincendeau M; Plettenburg O; Sattler M; Krappmann D; Hadian K
    J Biol Chem; 2018 Aug; 293(34):13191-13203. PubMed ID: 29950522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
    Kim SO; Kim MR
    Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
    Shembade N; Ma A; Harhaj EW
    Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.